Profile data is unavailable for this security.
About the company
BioDlink International Co Ltd, formerly TOT BIOPHARM International Co Ltd, is a clinical-stage biopharmaceutical company principally engaged in developing and commercializing oncology drugs and therapies. The Company and its subsidiaries are primarily engaged in research, development, manufacturing, and marketing of anti-tumor drugs, contract development and manufacturing organization (CDMO) business and license-out of self-developed biological drugs in the People’s Republic of China. The Company owns a pipeline of oncology drug candidates, which include monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs). The Company has built and established a fully integrated in-house platform of discovery, process development, quality management, pre-clinical and clinical development, as well as commercial-scale manufacturing facilities and sales and marketing capabilities. The Company mainly conducts its businesses in the domestic market.
- Revenue in HKD (TTM)1.21bn
- Net income in HKD8.21m
- Incorporated2009
- Employees604.00
- LocationBioDlink International Co Ltd120 Changyang StreetSuzhou Industrial ParkSuzhou 215024ChinaCHN
- Phone+86 51 262965186
- Fax+86 51 262965286
- Websitehttps://www.biodlink.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cloudbreak Pharma Inc | 78.15m | -326.93m | 1.92bn | 60.00 | -- | -- | -- | 24.58 | -0.3897 | -0.3897 | 0.0932 | -3.08 | -- | -- | -- | 1,532,373.00 | -- | -- | -- | -- | -- | -- | -418.33 | -- | -- | -- | 19.44 | -- | -- | -- | 23.40 | -- | -- | -- |
| ImmuneOnco Biopharmaceuticls Shanghi Inc | 126.82m | -342.43m | 1.96bn | 195.00 | -- | 3.06 | -- | 15.48 | -0.8705 | -0.8705 | 0.3221 | 1.48 | 0.148 | -- | 3,865.48 | 812,941.60 | -40.09 | -- | -51.56 | -- | -- | -- | -270.79 | -- | -- | -- | 0.2236 | -- | 19,109.59 | -- | 16.76 | -- | -- | -- |
| Mabpharm Ltd | 479.59m | -31.09m | 2.10bn | 383.00 | -- | 18.81 | 57.03 | 4.39 | -0.0076 | -0.0076 | 0.1163 | 0.0271 | 0.4209 | 0.4659 | 4.05 | 1,522,523.00 | -2.73 | -19.62 | -4.02 | -25.69 | 86.40 | -- | -6.48 | -211.59 | 0.6906 | -1.58 | 0.7552 | -- | 196.27 | -- | 38.89 | -- | -12.13 | -- |
| Jiangsu Recbio Technology Co Ltd | 12.33m | -739.77m | 2.17bn | 507.00 | -- | 10.61 | -- | 176.26 | -1.55 | -1.55 | 0.0258 | 0.4242 | 0.006 | -- | -- | 23,220.65 | -36.26 | -31.31 | -64.03 | -37.31 | -- | -- | -5,990.59 | -- | 0.2767 | -100.74 | 0.8254 | -- | -- | -- | 1.67 | -- | 16.82 | -- |
| Frontage Holdings Corp | 1.98bn | 29.97m | 2.20bn | 1.54k | 73.12 | 0.8238 | 6.99 | 1.11 | 0.0148 | 0.0148 | 0.9735 | 1.31 | 0.4545 | 60.36 | 3.97 | 1,267,499.00 | 0.6902 | 3.05 | 0.8654 | 3.64 | 27.78 | 32.14 | 1.52 | 6.84 | 1.22 | 1.97 | 0.2861 | 0.00 | -1.90 | 20.48 | -92.68 | -46.72 | 13.29 | -- |
| Antengene Corp Ltd | 95.43m | -258.61m | 2.34bn | 152.00 | -- | 2.70 | -- | 24.56 | -0.4162 | -0.4162 | 0.1536 | 1.28 | 0.0619 | 1.51 | 3.20 | 564,671.80 | -16.77 | -48.14 | -19.52 | -53.06 | 78.54 | -- | -271.00 | -1,460.93 | 4.41 | -- | 0.2346 | -- | 36.62 | -- | 45.07 | -- | 259.46 | -- |
| Hanx Biopharmaceuticals (Wuhan) Co Ltd | -100.00bn | -100.00bn | 2.62bn | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -52.30 | -- | -- | -- |
| Clover Biopharmaceuticals Ltd | 58.57m | -1.03bn | 2.86bn | 243.00 | -- | -- | -- | 48.76 | -0.8194 | -0.8194 | 0.0466 | -1.49 | 0.0433 | 0.0547 | 47.89 | 195,238.00 | -76.07 | -75.37 | -- | -188.14 | 62.57 | -- | -1,756.85 | -13,419.00 | 0.2541 | -- | -- | -- | -2.13 | -- | -552.11 | -- | -24.90 | -- |
| BioDlink International Co Ltd | 1.21bn | 8.21m | 3.25bn | 604.00 | 370.88 | 3.92 | 35.55 | 2.69 | 0.0113 | 0.0113 | 1.66 | 1.07 | 0.7275 | 2.35 | 5.49 | 1,975,381.00 | 0.495 | -11.37 | 0.6586 | -14.89 | 71.10 | 73.14 | 0.6805 | -24.91 | 1.68 | 1.83 | 0.3519 | -- | 40.70 | 89.20 | 192.05 | -- | 27.04 | -- |
| Hua Medicine | 419.33m | 1.22bn | 3.30bn | 285.00 | 2.55 | 2.56 | 2.62 | 7.86 | 1.23 | 1.23 | 0.4248 | 1.22 | 0.2411 | 1.76 | 5.71 | 2,496,030.00 | 69.99 | -21.83 | 82.64 | -25.31 | 52.55 | -- | 290.30 | -395.24 | 7.00 | -- | 0.2038 | -- | 234.02 | -- | -18.42 | -- | -17.81 | -- |
| Medtide Inc | -100.00bn | -100.00bn | 3.61bn | 520.00 | -- | 2.17 | -- | -- | -- | -- | -- | 11.72 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 4.48 | -- | 0.0335 | -- | 31.31 | -- | 21.00 | -- | -- | -- |
| Visen Pharmaceuticals | -100.00bn | -100.00bn | 3.88bn | 54.00 | -- | 3.70 | -- | -- | -- | -- | -- | 9.22 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0014 | -- | -- | -- | 26.98 | -- | -- | -- |
| Qyuns Therapeutics Co Ltd | 362.43m | -216.98m | 4.61bn | 337.00 | -- | 17.79 | -- | 12.71 | -0.9769 | -0.9769 | 1.63 | 1.15 | 0.2903 | 4.05 | 9.14 | 1,069,106.00 | -17.90 | -- | -28.45 | -- | 72.44 | -- | -61.64 | -- | 1.43 | -23.19 | 0.7466 | -- | -- | -- | 33.91 | -- | -- | -- |
| Jacobio Pharmaceuticals Group Co Ltd | 227.81m | -51.64m | 4.80bn | 211.00 | -- | 4.90 | -- | 21.06 | -0.0667 | -0.0667 | 0.2945 | 1.24 | 0.1547 | -- | 7.97 | 886,437.60 | -3.51 | -36.09 | -4.01 | -39.58 | 100.00 | 65.67 | -22.67 | -283.16 | -- | -- | 0.1415 | -- | 145.13 | -- | 56.64 | -- | 29.33 | -- |
| TYK Medicines Inc | 121.05k | -316.86m | 4.85bn | 163.00 | -- | 11.72 | -- | 40,063.00 | -0.8545 | -0.8545 | 0.0003 | 1.09 | 0.0002 | -- | -- | 791.18 | -42.68 | -- | -- | -- | 13.08 | -- | -263,981.30 | -- | -- | -- | 0.3215 | -- | -- | -- | -1.18 | -- | -- | -- |
